•Arm Q2 results continue to demonstrate strong year-over-year growth in royalty revenue and annualized contract value (ACV). Revenue rose 5% year-over-year to $84400万 due to record levels of royalty revenue and continued strength in license revenue.
•Royalty revenue rose 23% year-over-year to $514 million, driven primarily by the continued adoption of Armv9 and smartphone market recovery. We estimate that Armv9 now contributes around 25%1 of royalty revenue, which is up from around 10% a year ago.
•License and other revenue declined 15% year-over-year as expected to $3.3 billionです高額なライセンス契約とバックログからの貢献のタイミングと規模の通常の変動のため、売上高が影響を受けました。Q2 予想通り、ブッキングは強かったです。
•GAAP当期純利益は107百万ドル、そして 67.2%, GAAPfully diluted earnings per share ("EPS") was $0.10 compared with $(0.11) in the same period a year ago. The non-GAAP effective tax rate expense was 5.6% and would have been 13.5% excluding a one-time benefit. Non-GAAP net income was $317 million, and non-GAAP fully diluted EPS was $0.30 compared with $0.36 in the same period a year ago.
•Free cash flow (FCF) for Q2 was $(65) million and for the trailing twelve months was $475 million. FCF for both periods was impacted by unfavorable movements in working capital related to deal specific payment structures and the timing of payments for employer taxes.
•Cash and cash equivalents and short-term investments totaled $2,358 million.
1 See the "Royalty technology mix" section on page 8 for more information.
各四半期、顧客とArm Chinaを通じて契約された既存のArm Total AccessおよびArm Flexible Accessライセンスの数を追跡します。私たちは時間の経過とともに、多くの顧客がArm Total AccessまたはArm Flexible Accessライセンスに移行し、製品にアクセスすることになると考えています。この移行により、契約交渉にほとんど時間を費やさず、むしろ、お互いの製品が将来のチップでどのように展開されるかに焦点を当てることができます。
既存のArm Total AccessおよびArm Flexible Accessライセンスの数をキー・パフォーマンス・インジケーターと見なしています。これらは私たちと顧客との間の協力関係が増加していることを示し、これは今後弊社の製品で設計されるチップが増えることや、それに応じて将来の継続的なロイヤリティー収益が増加し、長期的な市場シェアの向上に繋がる可能性があることを表す先行指標になり得る。
年間契約価値("ACV")
各四半期、私たちは、顧客とArm Chinaを通じて締結されたライセンス契約に関連するACVを追跡します。これは、Arm Chinaとの知的財産ライセンス契約の下で共有された総ライセンス料に基づいています。私たちはACVを、各適用報告期間の最終日まで有効であると見做されるすべての締結契約に対して、潜在的な将来のロイヤリティー収益を除いた年間総契約料と定義しています。Arm Total Access契約とALAは、契約年数にわたり、有効と見做され、年間化されます。その他のライセンス契約(Arm Flexible Access契約またはテクノロジーライセンス契約の下に発行された単一利用および限定利用ライセンスを含む)は、顧客の歴史的なライセンシングの傾向に基づいて、有効と見做され、3年間にわたり年間化されます。Arm Chinaが共有する総ライセンス料も、有効と見做され、3年間にわたり年間化されます。
ここで提示される非GAAP財務指標には、取得関連の無形資産の償却、発行後の株式ベースの補償(“SBC”)費用(受取行為時に株式を発行する意図がある権利に関連)、この課税されるSBC株式ベース権利に関連する雇用主税金、これらの税金に関連する研究開発(“R&D”)税制のインセンティブ、を除外します。 一時的な従業員給与関連の特典、 Arm Limited All Employee Plan 2019(“2019 AEP”)、廃棄活動に関連する費用、有形固定資産の減損、事業の再編と関連費用、上場企業の準備費用、その他の営業収入(費用)、純(損失)、投資による利益の処分、非GAAP調整の所得税効果を除外しています。これらの項目は、非現金または一時的な性質であるため、またはこれらの項目の金額とタイミングが予測不可能であり、事業のコア業績によって導かれていないため、過去の期間と競合他社との比較が less意味がなくなります。
(1) Total SBC cost, including both cash and equity settled awards, was $676 million for the six months ended September 30, 2023. For non-GAAP purposes, we adjusted for those awards that were liability-classified prior to the IPO but were equity settled after the IPO. Liability-classified awards were remeasured at the end of each reporting period through the date of settlement to ensure that the expense recognized for each award was equivalent to the amount paid in cash or equity settled after the IPO.
(2) Non-GAAP net income includes $3 million of employer taxes related to SBC, net of the R&D tax incentives and the associated $5 million of income tax effect on non-GAAP adjustments which has been recast across historical periods for trend purposes.
This shareholder letter contains forward-looking statements that reflect our plans, beliefs, expectations and current views with respect to, among other things, future events and financial performance. These statements involve known and unknown risks, uncertainties and other important factors that may cause our actual results, levels of activity, performance or achievements to be materially different from the information expressed or implied by these forward-looking statements. There are many factors that could cause or contribute to such differences, including, but not limited to, those identified below and those discussed in “Item 3. Key Information—D. Risk Factors” in our Annual Report on Form 20-F for the fiscal year ended March 31, 2024, filed with the SEC on May 29, 2024.
This shareholder letter contains forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact could be deemed forward-looking statements, including without limitation, statements relating to our future operations, results of operations and other matters that are based on our current expectations, estimates, assumptions and projections. In some cases, you can identify forward-looking statements because they contain words such as “may,” “might,” “will,” “could,” “would,” “should,” “expect,” “is/are likely to,” “intend,” “plan,” “objective,” “anticipate,” “believe,” “estimate,” “predict,” “potential,” “target,” “continue,” “ongoing” or similar words or phrases, or the negative of these words or phrases. The inclusion of forward-looking statements in this shareholder letter should not be regarded as a representation by us or any other person that the future plans, estimates or expectations contemplated by us will be achieved or that we have conducted an exhaustive inquiry into, or review of, all potentially available relevant information. The forward-looking statements included in this shareholder letter are based on management’s current beliefs, assumptions and expectations of our future economic performance, considering the information currently available to management. While we believe such information forms a reasonable basis for such statements, such information may be limited or incomplete. Accordingly, there are, or will be, important factors that could cause our actual results to differ materially from those indicated in these statements. All such factors are difficult to predict, represent uncertainties that may materially affect actual results and may be beyond our control. New risk factors emerge from time to time, and it is not possible for management to predict all such risk factors or to assess the impact of each such risk factor on the Company. Any forward-looking statement in this shareholder letter speaks only as of the date hereof, and we do not undertake any obligation to update any forward-looking statement to reflect events or circumstances after the date of this shareholder letter except as required by applicable law. If one or more risks or uncertainties materialize, or if our underlying assumptions prove to be incorrect, our actual results may vary materially from what we may have expressed or implied by these forward-looking statements. We caution that you should not place undue reliance on any of our forward-looking statements.